Browse by category

Weight loss drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are transforming obesity treatment, but without affordable, healthy food and appropriate support, they could widen health inequalities in the UK, according to researchers at University College London and the University of Cambridge, UK. The researchers argue that while incretin-based therapies, also known as weight loss medications, have transformed obesity treatment, their long-term benefits ma